425 related articles for article (PubMed ID: 31059014)
1. lnc-PKD2-2-3, identified by long non-coding RNA expression profiling, is associated with pejorative tumor features and poor prognosis, enhances cancer stemness and may serve as cancer stem-cell marker in cholangiocarcinoma.
Qiu G; Ma D; Li F; Sun D; Zeng Z
Int J Oncol; 2019 Jul; 55(1):45-58. PubMed ID: 31059014
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC00665 promotes gemcitabine resistance of Cholangiocarcinoma cells via regulating EMT and stemness properties through miR-424-5p/BCL9L axis.
Lu M; Qin X; Zhou Y; Li G; Liu Z; Geng X; Yue H
Cell Death Dis; 2021 Jan; 12(1):72. PubMed ID: 33436545
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
Li Y; Cai Q; Li W; Feng F; Yang L
Biochem Biophys Res Commun; 2018 Oct; 504(4):654-659. PubMed ID: 30205958
[TBL] [Abstract][Full Text] [Related]
4. Profiling of downregulated blood-circulating miR-150-5p as a novel tumor marker for cholangiocarcinoma.
Wu X; Xia M; Chen D; Wu F; Lv Z; Zhan Q; Jiao Y; Wang W; Chen G; An F
Tumour Biol; 2016 Nov; 37(11):15019-15029. PubMed ID: 27658773
[TBL] [Abstract][Full Text] [Related]
5. Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion.
Li Z; Li J; Ji D; Leng K; Xu Y; Huang L; Jiang X; Cui Y
Gene; 2018 Mar; 645():131-136. PubMed ID: 29246536
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA HOTAIR promotes tumorigenesis and forecasts a poor prognosis in cholangiocarcinoma.
Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Gao J; Cui Y; Zhong X
Sci Rep; 2018 Aug; 8(1):12176. PubMed ID: 30111807
[TBL] [Abstract][Full Text] [Related]
7. Enhanced expression of lncRNA TP73-AS1 predicts adverse phenotypes for cholangiocarcinoma and exerts oncogenic properties in vitro and in vivo.
Yao Y; Sun Y; Jiang Y; Qu L; Xu Y
Biomed Pharmacother; 2018 Oct; 106():260-266. PubMed ID: 29966969
[TBL] [Abstract][Full Text] [Related]
8. A novel five-lncRNA signature panel improves high-risk survival prediction in patients with cholangiocarcinoma.
Xie X; Wang Y; Zhang S; Li J; Yu Z; Ding X; Ye L; Gong P; Zhu Q; Li J; Chen Z; Yao X; Du Z; Zeng Q; Chen H; Yang Z; Chen G
Aging (Albany NY); 2021 Jan; 13(2):2959-2981. PubMed ID: 33472169
[TBL] [Abstract][Full Text] [Related]
9. LncRNA CCAT1 as the unfavorable prognostic biomarker for cholangiocarcinoma.
Jiang XM; Li ZL; Li JL; Zheng WY; Li XH; Cui YF; Sun DJ
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(6):1242-1247. PubMed ID: 28387907
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma.
Padthaisong S; Thanee M; Namwat N; Phetcharaburanin J; Klanrit P; Khuntikeo N; Titapun A; Sungkhamanon S; Saya H; Loilome W
J Transl Med; 2020 Feb; 18(1):64. PubMed ID: 32039729
[TBL] [Abstract][Full Text] [Related]
11. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding-RNA component of mitochondrial RNA processing endoribonuclease is involved in the progression of cholangiocarcinoma by regulating microRNA-217.
Tang L; Wang Y; Wang H; Xu B; Ji H; Xu G; Ge X; Li Q; Miao L
Cancer Sci; 2019 Jul; 110(7):2166-2179. PubMed ID: 31111617
[TBL] [Abstract][Full Text] [Related]
14. E2F1-induced upregulation of long non-coding RNA LMCD1-AS1 facilitates cholangiocarcinoma cell progression by regulating miR-345-5p/COL6A3 pathway.
Yu J; Zhang B; Zhang H; Qi Y; Wang Y; Wang W; Wang Y; Wang Y
Biochem Biophys Res Commun; 2019 Apr; 512(2):150-155. PubMed ID: 30876691
[TBL] [Abstract][Full Text] [Related]
15. Expression of long non-coding RNA ANRIL predicts a poor prognosis in intrahepatic cholangiocarcinoma.
Angenard G; Merdrignac A; Louis C; Edeline J; Coulouarn C
Dig Liver Dis; 2019 Sep; 51(9):1337-1343. PubMed ID: 31040073
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of long noncoding RNA H19 indicates a poor prognosis for cholangiocarcinoma and promotes cell migration and invasion by affecting epithelial-mesenchymal transition.
Xu Y; Wang Z; Jiang X; Cui Y
Biomed Pharmacother; 2017 Aug; 92():17-23. PubMed ID: 28528181
[TBL] [Abstract][Full Text] [Related]
17. Global identification and characterization of lncRNAs that control inflammation in malignant cholangiocytes.
Han BW; Ye H; Wei PP; He B; Han C; Chen ZH; Chen YQ; Wang WT
BMC Genomics; 2018 Oct; 19(1):735. PubMed ID: 30305026
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma.
Zhang D; Li H; Xie J; Jiang D; Cao L; Yang X; Xue P; Jiang X
Int J Oncol; 2018 Jun; 52(6):1777-1786. PubMed ID: 29620172
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of aberrantly expressed profiles of lncRNAs, miRNAs and mRNAs with associated ceRNA network in cholangiocarcinoma.
Wang X; Hu KB; Zhang YQ; Yang CJ; Yao HH
Cancer Biomark; 2018; 23(4):549-559. PubMed ID: 30452401
[TBL] [Abstract][Full Text] [Related]
20. AR-induced ZEB1-AS1 represents poor prognosis in cholangiocarcinoma and facilitates tumor stemness, proliferation and invasion through mediating miR-133b/HOXB8.
Jiang X; Li J; Wang W; Hu Z; Guan C; Zhao Y; Li W; Cui Y
Aging (Albany NY); 2020 Jan; 12(2):1237-1255. PubMed ID: 31978895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]